Global Interventional Oncology Devices Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

By Product;

Embolization Devices, Ablation Devices, and Support Devices.

By Procedure;

Thermal Tumor Ablation, Non-thermal Tumor Ablation, Transcatheter Arterial Chemoembolization (TACE), Transcatheter Arterial Radioembolization (TARE), or Selective Internal Radiation Therapy (SIRT), and Transcatheter Arterial Embolization (TAE), or Bland Embolization.

By Cancer Type;

Liver Cancer, Kidney Cancer, Lung Cancer, Bone Cancer, and Others.

By Geography;

North America, Europe, Asia Pacific, Middle East and Africa and Latin America - Report Timeline (2021 - 2031).
Report ID: Rn152431252 Published Date: January, 2025 Updated Date: February, 2025

Introduction

Global Interventional Oncology Devices Market (USD Million), 2021 - 2031

In the year 2024, the Global Interventional Oncology Devices Market was valued at USD 2,424.99 million. The size of this market is expected to increase to USD 4,577.29 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 9.5%.

The Global Interventional Oncology Devices Market encompasses a broad spectrum of medical devices and equipment utilized in the diagnosis, treatment, and management of various cancers through minimally invasive procedures. This market is experiencing robust growth driven by several factors, including technological advancements, increasing cancer incidence, and a shift towards minimally invasive treatment modalities.

Interventional oncology procedures involve the use of specialized devices such as radiofrequency ablation (RFA) devices, microwave ablation devices, cryoablation devices, and transarterial chemoembolization (TACE) systems, among others, to target and destroy cancerous tumors. These devices offer patients less invasive alternatives to traditional surgery, with benefits such as reduced recovery times, fewer complications, and improved quality of life.

One of the key drivers of market growth is the rising incidence of cancer worldwide. As cancer rates continue to climb, there is a growing need for effective and less invasive treatment options that can be delivered with precision. Additionally, technological advancements in interventional oncology devices, such as improved imaging modalities and navigation systems, are enhancing the accuracy and safety of cancer treatments, further driving market expansion.

Geographically, North America and Europe currently dominate the interventional oncology devices market, owing to factors such as well-established healthcare infrastructure, high adoption rates of advanced medical technologies, and increasing investment in cancer research and treatment. However, emerging markets in Asia-Pacific and Latin America are also witnessing rapid growth, fueled by expanding healthcare infrastructure, rising healthcare expenditure, and growing awareness about the benefits of minimally invasive cancer treatments.

The Global Interventional Oncology Devices Market is poised for continued growth as technological innovation continues to drive the development of more advanced and effective devices, and as healthcare systems worldwide increasingly recognize the value of minimally invasive approaches in cancer care.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Product
    2. Market Snapshot, By Procedure
    3. Market Snapshot, By Cancer Type
    4. Market Snapshot, By Region
  4. Global Interventional Oncology Devices Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Increasing Incidence of Cancer
        2. Technological Advancements
        3. Growing Preference for Minimally Invasive Procedures
      2. Restraints
        1. High Cost of Interventional Oncology Procedures
        2. Stringent Regulatory Approval Process
        3. Limited Awareness and Accessibility
      3. Opportunties
        1. Emerging Markets
        2. Expanding Applications
        3. Collaborations and Partnerships
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Global Interventional Oncology Devices Market, By Product, 2021 - 2031 (USD Million)
      1. Embolization Devices
      2. Ablation Devices
      3. Support Devices
    2. Global Interventional Oncology Devices Market, By Procedure, 2021 - 2031 (USD Million)
      1. Thermal Tumor Ablation
      2. Non-thermal Tumor Ablation
      3. Transcatheter Arterial Chemoembolization (TACE)
      4. Transcatheter Arterial Radioembolization (TARE) or Selective Internal Radiation Therapy (SIRT)
      5. Transcatheter Arterial Embolization (TAE) or Bland Embolization
    3. Global Interventional Oncology Devices Market, By Cancer Type, 2021 - 2031 (USD Million)
      1. Liver Cancer
      2. Kidney Cancer
      3. Lung Cancer
      4. Bone Cancer
      5. Others
    4. Global Interventional Oncology Devices Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. Boston Scientific Corporation
      2. Medtronic plc
      3. Terumo Corporation
      4. Merit Medical Systems, Inc
      5. Philips Volcano
  7. Analyst Views
  8. Future Outlook of the Market